Amerikanische Gesellschaft für Hirudotherapie

The leech: a novel invertebrate model for studying muscle regeneration and diseases

Review published in Curr Pharm Des (2010)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewArzneimittelentwicklungSpeichel-PharmakologieGrimaldi A et al. · Current pharmaceutical design, 2010

Abstract

We focused our studies on the leech, Hirudo medicinalis. This invertebrate has a relative anatomical simplicity and is a reliable model for studying a variety of basic events, such as tissue repair, which has a striking similarity with vertebrate responses. Hirudo is also a good invertebrate model to test the actions of drugs and gene products, since the responses evoked by the different stimuli are clear and easily detectable due to their small size and anatomical simplicity. Here we review the use of this invertebrate model to investigate muscle regeneration and the role of hematopoietic stem cells in this process. Our recent data, summarized in this review, demonstrate that the injection of an appropriate combination of the matrigel biopolymer supplemented with Vascular Endothelial Growth factor (VEGF) in the leech Hirudo medicinalis is a remarkably effective tool for isolating a specific population of hematopoietic/endothelial precursor cells, which in turn can differentiate in muscle cells. Thus leeches can be considered as a new emerging model for studying endothelial and hematopoietic precursors cells involved in muscle post-natal growth and regeneration processes.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov'tReview
Indexed MeSH termsAnimalsCell Culture TechniquesCell DifferentiationCytokinesHematopoietic Stem CellsHirudo medicinalisModels, AnimalMusclesMyoblasts, SkeletalRegenerationVascular Endothelial Growth Factor AWound Healing

Zusammenfassung

Reviews Hirudo medicinalis as a model for muscle regeneration: matrigel plus VEGF injection isolates a population of hematopoietic/endothelial precursor cells that can differentiate into muscle cells, useful for studying postnatal regeneration.

Warum dies für die Hirudotherapie relevant ist

This review examined the use of Hirudo medicinalis as an invertebrate model for studying muscle regeneration, tissue repair, and the role of hematopoietic stem cells, including data showing that VEGF-supplemented matrigel injection isolates hematopoietic/endothelial precursor cells capable of differentiating into muscle cells. It is tangentially relevant to ASH's domain in that it positions the medicinal leech as a research organism for studying biological processes—tissue repair, stem cell biology—that may indirectly inform understanding of wound healing and regeneration. However, this study uses the leech as an experimental model organism, not as a therapeutic agent or source of therapeutic secretome compounds; it does not address hirudotherapy, leech saliva, or leech-derived anticoagulants. Its relevance to ASH's core domain is therefore limited to the leech as a biological subject rather than as a therapeutic modality.

Zitation

The leech: a novel invertebrate model for studying muscle regeneration and diseases.

Grimaldi A et al. · Current pharmaceutical design, 2010

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 26, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.